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Background: Long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs)are involved in the 
progression of discoid lupus erythematosus (DLE), but an understanding of their underlying mechanisms 
remains elusive. To explore the expression profiles of lncRNAs and circRNAs in DLE, we surveyed the 
lncRNA/circRNA and mRNA expression profiles in the epithelia of oral DLE and adjacent normal tissues. 
Methods: The lesional and non-lesional lower lips of three DLE patients were analysed by RNA-
sequencing (RNA-seq). The principal functions of the significantly deregulated genes were identified using 
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment 
analyses. And the correlated expression networks (coding-noncoding co-expression and lncRNAs-
transcription factor-mRNA) were evaluated as well.
Results: Hundreds of significantly changed lncRNAs and mRNAs and dozens of significantly changed 
circRNAs were identified. lncRNA lnc-MIPOL1-6 and IncRNA IncDDX47-3 expressions were correlated 
with immune response-related genes, including IL19, CXCL1, CXCL11, and TNFSF15. Up-regulated 
IncRNA-TF network consists of 8 TFs and 74 related lncRNAs. The lncRNA-TF-gene trans-regulation 
consisting of 204 lncRNAs,39 TFs, and correlated 3 genes.
Conclusions: These results demonstrate that lncRNAs and circRNAs can influence the progression of 
DLE. Certain mRNAs/lncRNAs/circRNAs may have substantial value in DLE diagnosis and therapy.
Keywords: Discoid lupus erythematosus (DLE); long noncoding RNAs (lncRNAs); circular RNAs (circRNAs); 
RNA-sequencing (RNA-seq)
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Introduction
As a chronic inflammatory cutaneous disease, discoid lupus 
erythematosus (DLE), unless diagnosed and treated in a 
timely fashion, can lead to disfiguring scarring and skin 
atrophy (1,2). DLE lesions occur in approximately 6–10% 
of patients with systemic lupus erythematosus (SLE) (3,4). 
Although there are similarities in histology, their clinical 
course and prognosis are different, suggesting different 
pathogeneses (5). DLE’s pathophysiology has not been 
extensively investigated and is likely related to a complex 
of environmental, genetic, and immune cell interactions. 
Recent studies have found that dendritic cells, natural killer 
cells, and toll-like receptors play a dominant role in this 
process. Other evidence has also shown that, compared with 
healthy and involved DLE skin, there are several signaling 
pathways related to T helper (Th) type 1 in lesional DLE (4). 
However, the understanding of key pathogenic pathways is 
far from clear.
An increasing number of high-throughput deep 
sequencing results have found that only a small proportion 
of the human genome is transcribed into protein-coding 
mRNAs, while most genome is transcribed into noncoding 
RNAs (ncRNAs) (6-8), which are considered a new type 
of long noncoding RNA (lncRNA) with a length of more 
than 200 nucleotides (9-11). Recent evidences suggest that 
lncRNAs are involved many pathophysiological mechanisms, 
and are frequently deregulated (12-14) in autoimmune 
thyroid disease and rheumatoid arthritis (RA) (9). However, 
the functional and genomic profile of lncRNAs in DLE 
remains unclear. As a new topic in scientific literature, 
noncoding and circular RNAs (circRNAs) with a covalently 
closed loop structure (15,16) have been already mostly 
described in eukaryotic cells (17). They can occur in any 
part of genome and regulate gene expression (17,18). In 
recent years, circRNAs have been found to have numerous 
functional microRNA binding sites and occupy the role 
of miRNA regulators of gene expression. Accumulating 
evidence show that circRNAs are part  of  various 
physiological and pathological conditions, including cancer, 
prion infection, neurological disorders, and atherosclerotic 
vascular diseases (17-21). Despite this knowledge, little is 
known about the functional roles of circRNA in DLE, and 
the expression profiles of the noncoding RNAs role in the 
progression of DLE remain elusive.
We therefore evaluated the differential pattern expression 
of lncRNA/mRNA/circRNA in order to explore the 
molecular profiles of non-coding RNAs in DLE by high-
throughput RNA-sequencing (RNA-seq). We initially 
analyzed their pathways, Gene Ontology (GO) items, 
functional coding-noncoding co-expression networks, and 
TF-lncRNA-enriched mRNA networks. Our results from 
this analysis demonstrate that numerous lncRNAs and 
circRNAs have potential to be considered diagnostic and 
therapeutic markers for DLE. Finally, the functions of the 
lncRNAs and circRNAs were predicted by evaluating the 
differences of expression in lncRNA/circRNA/mRNA co-
expression networks. These results provide further insight 
into the underlying pathogenesis of DLE and offer targets 
for DLE therapy.
Methods
Patients and lower lip samples
After written consent was given, a punch biopsy of 6 mm 
was performed in each of the 3 patients affected by DLE 
from the lesional and non-lesional lower lips. All samples 
were evaluated by histology. The local ethics committee of 
Shanghai Ninth People’s Hospital approved this study.
RNA collection, library preparation, and sequencing
Total RNAs of DLE and normal control samples were 
extracted using the TriZol Isolation Kit (Ambion). The 
libraries were constructed and sequenced on the Illumina 
sequencing platform (HiSeqTM 2500 or other platforms) 
according to the manufacturer’s instructions. 
Differential expression
The statistical significance of differentially expressed 
lncRNAs/circRNAs/mRNAs between the DLE group and 
normal control group was identified by P value and FDR 
filtering (fold change ≥2.0, P<0.05, and FDR <0.05). The 
overview of the characteristics of expression profiles was 
shown by hierarchical clustering.
Correlation analysis
The Pearson correlation coefficient (PCC ≥0.90, P value 
<0.01, and FDR <0.01) between genes was calculated to 
perform the co-expression analysis according to their 
expression levels. 
GO and pathway analysis
GO and Kyoto Encyclopedia of Genes and Genomes 
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(KEGG) pathway analysis were performed as previously 
described.
Cis and trans regulation prediction
As previously described (22), mRNAs co-expressed with 
lncRNAs which significantly overlapped with the target 
genes of a given transcription factor were enriched, and the 
lncRNAs-TF mRNA network was established. 
Results
The expression of mRNA, lncRNA, and circRNA profiles 
Thousands of transcripts were detected by the RNA-seq 
in DLE and adjacent normal tissues (Figure 1). A total of 
555 mRNAs (Figure 1A) and 507 lncRNAs (Figure 1B) were 
found to be differentially expressed with fold change ≥2.0, 
P<0.05, and FDR <0.05. Among them, 204 and 351 mRNAs 
were upregulated and downregulated, respectively. A 
total of 198 and 309 lncRNAs were upregulated and 
downregulated in 3 DLE tissues compared with adjacent 
normal controls, respectively. Moreover, filtering analysis 
(fold change ≥2.0, P<0.05. and FDR <0.05) identified a total 
of 62 (30 up-regulated and 32 down-regulated) differentially 
expressed circRNAs (Figure 1C) in DLE compared with 
normal tissues. Furthermore, a total of 161 lncRNAs 
showed fold change ≥10 (up: 57, down: 104). HCP5 was 
the most upregulated lncRNA in DLE with a fold change 
of almost 206, compared with the adjacent normal tissue. 
Hierarchical clustering demonstrated that mRNA, lncRNA, 
and circRNA expression patterns among DLE tissues were 
distinguishable and different from those in the matched 
normal tissues. 
Accordingly, the detected lncRNAs were widely 
distributed in al l  chromosomes including the sex 
chromosomes X and Y (Figure 1D). According to their 
relation with protein-coding genes, the lncRNAs were 
divided into four categories (Figure 1E): antisense, sense 
overlapping, intergenic, intronic notably. Intergenic 
lncRNAs were the largest category (65.0%). From further 
analysis, the percentages of intergenic lncRNAs in up-
regulated and down-regulated lncRNAs in DLE compared 
with controls was 76.4% and 51.2%, respectively.
GO and KEGG pathway analysis
GO enrichment analysis of differentially expressed 
mRNAs indicated their role in dramatically regulating 
lncRNAs. Our data showed that the up-regulated mRNAs 
associated with biological processes, cellular components 
and molecular function, were immune response, integral 
components of plasma membrane, and chemokine activity, 
respectively (Figure 2A). Meanwhile, the down-regulated 
transcripts were most related to retina homeostasis, 
apical plasma membrane, and ligand-gated sodium channel 
activity (Figure 2B). Notably, based on GO terms, the 
immune and inflammatory response is important in the 
progression of DLE.
KEGG pathway enrichment analysis of differentially 
expressed mRNAs was performed to reveal the pathways 
and molecular interactions related to genes. We found 
20 pathways associated with upregulated mRNAs and 20 
related to downregulated mRNAs in the KEGG pathway 
enrichment analysis. As shown, the staphylococcus aureus 
infection and viral myocarditis signaling pathway were 
the top pathways in upregulated protein-coding genes 
(Figure 2C), whereas the top enriched KEGG pathway was 
aldosterone-regulated sodium reabsorption and salivary 
secretion for downregulated transcripts (Figure 2D). The 
result suggests that these pathways might be critical to the 
progression of DLE.
To determine  whether  c i rcRNAs regulate  the 
transcription of parental genes, the genes producing 
differently expressed circRNAs were divided by GO 
analysis. Compared to adjacent normal tissues, the gene 
expression profile of linear counterparts of differentially 
up-regulated circRNAs in the DLE group favored protein 
ubiquitination (biological progress), golgi membrane 
(cellular component) and transcription factor activity, 
and sequence-specific DNA binding (molecular function) 
(Figure 2E). Meanwhile, GO enrichment analysis of 
downregulated transcripts showed that the closely related 
GO terms were intracellular signal transduction (biological 
progress), apical plasma membrane (cellular component), 
and RNA polymerase II regulatory region sequence-specific 
DNA binding (molecular function) (Figure 2F). These 
results suggest that these molecular functions and biological 
process could be involved in DLE progression.
lncRNA/mRNA expression and function
As the functionality of most lncRNAs has thus far not been 
annotated, the functional prediction of lncRNAs was based 
on the annotation of the co-expressed mRNA function. To 
build a CNC network, we chose 37 significantly expressed 
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Figure 1 Expression profiles of lncRNAs, mRNAs, and circRNAs. (A,B,C) Hierarchical clustering of all differentially expressed lncRNAs 
(A), mRNAs (B), and circRNAs (C) in DLE groups and control groups from DLE and adjacent normal tissues. (D) A circos plot showing 
lncRNAs on human chromosomes. The outermost layer of the circos plot is a chromosome map of the human genome. The second 
circle shows the distribution of differentially expressed lncRNAs on the chromosomes, with the red line indicating up-regulation and the 
green line indicating down-regulation. The third circle is the histogram of differentially expressed lncRNAs at different positions, with 
red indicating up-regulated lncRNAs and green indicating down-regulated lncRNAs. The higher the column, the higher the number of 
differentially expressed genes. The fourth circle shows the distribution of differentially expressed mRNAs on the chromosomes, with the 
same color distribution as lncRNA. The innermost circle was the histogram of differentially expressed mRNAs at different positions, with 
the same color distribution as lncRNA. (E) Different types and counts of lncRNAs (fold change ≥2.0, P<0.05 and FDR <0.05). Fourtypes of 
lncRNAs have been classified according to the relationship and genomic loci with their associated coding genes. lncRNAs, long noncoding 
RNAs; circRNAs, circular RNAs.
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coding genes in the DLE group according to the degree 
of correlation (Figure 3). The mRNAs were involved in 
several biological processes, including immune response, 
immunological synapse, and T cell activation. The network 
indicated that up-regulated lncRNA lnc-MIPOL1-6 was 
positively correlated, and down-regulated lncRNA lnc-
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DDX47-3 was negatively correlated with IL19, CXCL1, 
CXCL11, and TNFSF15, which are involved in immune 
response. The co-expression network suggested that 
mRNA or lncRNA might be associated with one to dozens 
of lncRNAs, and the regulation between lncRNAs and 
mRNAs is implicated in DLE.
Figure 2 Pathway and gene Ontology (GO) analysis. (A,B) Up (A) and down (B) regulated mRNAs of GO with top 10 enrichment scores 
representing domains of biological processes and molecular functions (C,D). Up- (C) and down- (D) of KEGG pathway enrichment 
analysis with top 20 enrichment scores. (E,F). Up- (E) and down- (F) GO annotation of the linear counterparts of regulated circRNAs. Both 
circRNAs showed a significantly changed with fold change ≥2.0, P<0.05, and FDR <0.05. circRNAs, circular RNAs.
A B
C D
E F
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Cis and the trans-regulating function prediction of lncRNAs 
We further analyzed how the dysregulated mRNAs 
might play a cis or trans-regulatory role in lncRNA genes 
according to co-expression. We then built a correlated 
expression network to identify the relation between the 8 
mRNAs and their adjacent coding gene. The 8 differentially 
expressed mRNAs were chosen to hunt their nearby coding 
Figure 3 The figure showed 37 significant mRNAs as a co-expression network with their associated lncRNAs. The network is expressed as 
Pearson’s correlation coefficient (the absolute value of PCC ≥0.90, P value <0.01, and FDR <0.01); the solid lines are positive correlations 
while the dashed lines represent negative correlations. lncRNAs, long noncoding RNAs.
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genes. The co-expressed lncRNAs genes were defend as co-
regulated genes with one differentially expressed mRNA 
on the same chromosome within 300 kb (Figure 4). This 
network could provide valuable clues about the mRNAs 
adjacent to the lncRNAs genes.
To  f u r t h e r  e v a l u a t e  t h e  r o l e  o f  l n c R N A s  i n 
DLE, according to the enrichment with cumulative 
hypergeometric test, we searched the TFs correlated 
with lncRNAs and constructed a co-expression network 
by combining differentially expressed lncRNAs with 
TFs. We then predicted the trans-regulatory functions of 
lncRNAs by the TFs that could regulate their expression. 
Some lncRNAs might be involved in particular pathways 
regulated by TFs, supposing lncRNAs could have trans-
regulatory functions. Therefore, we analyzed the co-
expressed mRNAs with these TF-regulated mRNAs and 
lncRNAs. With the threshold of FDR <0.01 and P<0.01, 
each lncRNA could connect with one to a dozen TFs and 
each pair of lncRNA-TF resulted in the enrichment of 
several genes (Figure 5A)—a discovery which may provide 
critical data for subsequent research. As shown in Figure 4A, 
dysregulated lncRNAs were found to correspond to 8 TFs. 
Next, we further introduced mRNAs to build the ternary 
network of TF-lncRNA-mRNA base on TF-lncRNA binary 
analyses (Figure 5B). The results demonstrate that most of 
the lncRNAs participated in pathways regulated by TFs 
(STAT4, ETV6, and ZNF597), suggesting that these TFs 
could be correlated with the pathogenesis and development 
of DLE. 
Discussion
DLE is the most common form of cutaneous lupus 
erythematosus, accounting for approximately 80% of cases 
(1,4). Traditional research in gene regulation has focused 
on protein-coding genes, and a large number of non-
coding RNAs including lncRNAs and circRNAs have been 
described, (9,19,22). In particular, emerging evidence of 
deregulated lncRNA expression covering SLE (23-26) has 
implied that abnormal lncRNA expression may be involved 
in the progression of DLE. Recently, circRNAs were also 
reported to have a potential role in SLE (27-30). Thus far, 
however, a systematic analysis of noncoding RNA (lncRNAs 
and circRNAs) differential expression profiles in DLE 
has not been conducted. To further identify the functions 
in DLE, we evaluated lncRNA and circRNA expression 
profiles in the genome of 3 patients affected by DLE and 
matched adjacent tissues using high-throughout sequencing. 
We characterized lncRNA and circRNA expression using 
RNA-seq. A total of 507 (up: 198, down: 309) lncRNAs 
and 161 (up: 57, down: 104) circRNAs showed significant 
differential expression in DLE. Most of the deregulated 
lncRNAs (65%) belonged to the intergenic category. We 
further found that the differential expression of lncRNAs 
was highlighted on each chromosome, suggesting that 
each chromosome was associated with different degrees of 
Figure 4 Cis regulation of lncRNAs and their potential nearby genes are shown in the network. lncRNAs, long noncoding RNAs.
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Figure 5 Query lncRNAs and connection of enrichment transcription factors. (A) Up-regulated lncRNA-TF network consists of 8 TFs 
and 74 related lncRNAs; connected by 100 edges. (B) The lncRNA-TF-gene trans-regulation consisting of 204 lncRNAs, 39 TFs, and 
correlated 3 genes. lncRNAs, long noncoding RNAs.
A
B
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abnormality in DLE progression. As reported previously, 
our data also revealed a 13-fold up-regulation of 
macrophage migration inhibitory factor (MIF) in DLE. It 
was been shown that MIF has a crucial role as a regulator 
in acute and chronic immuno-inflammatory conditions 
like atherosclerosis, RA, and more recently, SLE (31,32). 
Of note, our data also showed that a 205-fold increase of 
lncRNA HCP5 in DLE, which was also reported to be 
associated with disease development in SLE (33). Other 
dysregulated lncRNAs of the present study were also 
found and verified in other studies. However, most of the 
differentially expressed lncRNAs are reported here for the 
first time. 
Compared with the adjacent normal controls, the most 
significant annotation results which were derived from GO 
items were immune response, inflammatory response, and 
T cell co-stimulation in the DLE group, suggesting that 
deregulated mRNAs may play a crucial role in the pathways 
of regulation for DLE. KEGG pathway analysis revealed 
that 20 pathways could contribute to the pathogenesis of 
DLE including staphylococcus aureus infection and viral 
myocarditis signaling pathway. This further suggests that 
the dysregulated activation of the immune system function 
is strongly correlative with DLE.
With the construction of the CNC co-expression 
network, many lncRNA expression levels were found 
to be associated with the expression of several mRNAs. 
Therefore, we established a CNC network to deeply 
analyze the connections between dysregulated lncRNAs and 
mRNAs. Some major linked mRNAs have been described as 
being connected to DLE, including lnc-DDX47-3. We thus 
supposed that lncRNAs may be related to the pathogenesis 
of DLE via a regulation of gene co-expression (IL19, 
CXCL1, CXCL11, and TNFSF15).
Finally, we constructed another network of lncRNA-TFs. 
Emerging evidence has shown that some TFs are involved 
in the progression of DLE. Therefore, a compositive 
analysis of TFs and differential co-expression genes may 
help to better understand the pathogenesis of DLE. In this 
study, we found that STAT4, ETV6, and ZNF597 were the 
most important TFs. Several studies identified a few of them 
as possible factors promoting the progression of DLE, but, 
the underlying mechanisms for this process remain elusive. 
Several STAT4 genes targets are reported to be enriched to 
functional pathways in the type I interferon system, and to 
have key roles in inflammatory response (34-36). Therefore, 
STAT4 has ability to influence the regulation many target 
genes, which may be closely related to their relationship 
with DLE. However, further study is needed to investigate 
the relationship between lncRNA-TFs and DLE.
In summary, we underlined a profile of dysregulated 
mRNAs/lncRNAs/circRNAs which may be prospectively 
useful in clinical practice for identifying possible markers 
with critical roles in the development of DLE. These results 
have revealed that certain mRNAs/lncRNAs/circRNAs may 
have substantial value in DLE diagnosis and therapy.
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